After a busy trade deadline, the New York Mets can finally shift their focus to what matters most over the remainder of the ...
We take a look at the Jacksonville Jaguars' 10-player rookie draft class after the seventh training camp practice, including ...
A decade ago, The Process was still causing controversy in Philly, LeBron James was fresh off his third ring and the 73-9 ...
5-Minute Crafts on MSN
10 acts of kindness that teach us compassion is still what every happy person practices daily in 2026
Some of the most compassionate people in 2026 are the coach who noticed, the neighbor who knocked, the stranger who folded a ...
Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveraging its first-in-class Flare platform, today announced the first participant has been dosed in a Phase 1 ...
With effect from the First Semester of 2026, Mathematics will no longer be a compulsory prerequisite for entry into ...
Sale Sharks youngsters among those to catch the eye in Malvern at launch of Prem Next Gen League and new player development strategy ...
Strong first full quarter of AVLAYAH™ (tividenofusp alfa-eknm) launch generated $3.6 million in net product revenueAdvanced TransportVehicle™ portfolio with two Alzheimer’s disease programs now in ...
The Toronto Maple Leafs took major strides to improve its pipeline of prospects this summer. Beyond Gavin McKenna, which ...
Planned IND submission for SZN-8141 in diabetic macular edema by the end of the third quarter of 2026 Expect to initiate SZN-8141 Phase 1b/2a study, DUET, by year-end 2026 with initial data ...
ROCKVILLE, Md., Aug. 6, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today reported financial results and operational highlights for the second quarter ended June 30, 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results